|
NUPL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.738300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.262300E-02 |
| Normal-vs-Stage2 |
9.876800E-01 |
| Normal-vs-Stage3 |
2.271600E-01 |
| Normal-vs-Stage4 |
2.141000E-01 |
| Stage1-vs-Stage2 |
1.853410E-01 |
| Stage1-vs-Stage3 |
5.088200E-01 |
| Stage1-vs-Stage4 |
6.074600E-01 |
| Stage2-vs-Stage3 |
3.722000E-01 |
| Stage2-vs-Stage4 |
3.737800E-01 |
| Stage3-vs-Stage4 |
9.408200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.672100E-02 |
| Normal-vs-AfricanAmerican |
8.432200E-01 |
| Normal-vs-Asian |
7.771600E-02 |
| Caucasian-vs-AfricanAmerican |
2.191600E-01 |
| Caucasian-vs-Asian |
4.911700E-02 |
| AfricanAmerican-vs-Asian |
2.015600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.766200E-02 |
| Normal-vs-Female |
2.010200E-01 |
| Male-vs-Female |
5.556000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.995200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.346400E-02 |
| Normal-vs-Age(61-80Yrs) |
3.635800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.127800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.809600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.775200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.923800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.838640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.862600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.781790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.531640E-01 |
| Normal-vs-Grade 2 |
1.435800E-01 |
| Normal-vs-Grade 3 |
8.387600E-02 |
| Normal-vs-Grade 4 |
2.274000E-01 |
| Grade 1-vs-Grade 2 |
4.576600E-01 |
| Grade 1-vs-Grade 3 |
6.619400E-01 |
| Grade 1-vs-Grade 4 |
6.355800E-01 |
| Grade 2-vs-Grade 3 |
8.166400E-01 |
| Grade 2-vs-Grade 4 |
9.695200E-01 |
| Grade 3-vs-Grade 4 |
8.922200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.648000E-02 |
| Normal-vs-ccB subtype |
7.154800E-01 |
| ccA subtype-vs-ccB subtype |
5.729700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.557000E-01 |
| Normal-vs-N1 |
7.977400E-01 |
| N0-vs-N1 |
9.374200E-01 |
|
|
